Literature DB >> 10950

Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.

G Koch.   

Abstract

1 The haemodynamic effects of labetalol 50 mg intravenously were studied in 13 hypertensive patients at rest in the supine and upright positions and during exercise using percutaneous right heart and brachial artery catheterization. 2 Labetalol induced immediate significant reductions in systolic and diastolic blood pressures in all conditions. 3 Heart rate, stroke volume and cardiac output were not significantly altered in the supine position at rest but were significantly reduced in the upright position. In addition systemic vascular resistance was significantly reduced. 4 During exercise, heart-rate, cardiac output and vascular resistance were significantly reduced; stroke volume was increased. Left ventriclac filling pressures were unchanged both at rest and during exercise. 5 It was concluded that these changes resulted from blockade to both alpha- and beta-adrenoreceptor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10950

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.

Authors:  G Koch
Journal:  Br Heart J       Date:  1979-02

Review 2.  Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.

Authors:  G Cocco; F Burkart; D Chu; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

Review 3.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

4.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

5.  Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.

Authors:  M Aggerbeck; G Guellaen; J Hanoune
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

Review 6.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

7.  Improved deep controlled hypotension in aneurysmal surgery.

Authors:  V Lüben; G Hempelmann
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

8.  The electrophysiological effects of intravenous labetalol in man.

Authors:  A Harley; H A Coverdale
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 10.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

Authors:  P Lund-Johansen
Journal:  Drugs       Date:  1984       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.